Self-transfer and mortality amongst adults lost to follow-up in ART programmes in low- and middle-income countries: Systematic review and meta-analysis

Tropical Medicine and International Health

Volumn 20, Issue 3, 2015, Pages 365-379

  Wilkinson, Lynne S ^a,d   Skordis Worrall, Jolene ^a   Ajose, Olawale ^b   Ford, Nathan ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CLINTON HEALTH ACCESS INITIATIVE   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

Antiretroviral therapy; Continuity of care; Human immunodeficiency virus; Lost to follow up; Mortality; Systematic review

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; DATABASE; META-ANALYSIS; MORTALITY; SENSITIVITY ANALYSIS; SPATIOTEMPORAL ANALYSIS;

ADULT; AFRICA SOUTH OF THE SAHARA; DEATH; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOWEST INCOME GROUP; META ANALYSIS; MIDDLE INCOME GROUP; MORTALITY; OUTCOME ASSESSMENT; REVIEW; RURAL AREA; SELF CARE; SELF TRANSFERRED CARE; SENSITIVITY ANALYSIS; SOCIOECONOMICS; SYSTEMATIC REVIEW; TELEPHONE; URBAN AREA; DEVELOPING COUNTRY; HIV INFECTIONS; PATIENT ATTITUDE; PATIENT TRANSPORT; STATISTICS AND NUMERICAL DATA;

AFRICA;

HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT TRANSFER;

EID: 84922578449     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12434     Document Type: Review

References (63)

1. Alamo ST, Colebunders R, Ouma J et al. (2012a) Socio-economic support reduces non-retention in care in a comprehensive community based program in Uganda. Journal of Acquired Immune Deficiency Syndromes 59, e52-e59.
2. Alamo ST, Colebunders R, Ouma J et al. (2012b) Return to normal life after AIDS as a reason for lost to follow-up in a community-based antiretroviral treatment program. Journal of Acquired Immune Deficiency Syndromes 60, e36-e45.
3. Avila D, Althoff KN, Mugglin C et al. (2014) Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. Journal of Acquired Immune Deficiency Syndromes 65, e8-e16.
4. Bisson GP, Gaolathe T, Gross R et al. (2008) Overestimates of survival after HAART: implications for global scale-up efforts. PLoS One 3, e1725.
5. Bor J, Herbst AJ, Newell M-L & Bärnighausen T (2013) Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 339, 961-965.
6. Boulle A, Bock P, Osler M et al. (2008) Antiretroviral therapy and early mortality in South Africa. Bulletin of the World Health Organization 86, 678-687.
7. Boulle A, Van Cutsem G, Hilderbrand K et al. (2010) Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 24, 563-572.
8. Brinkhof MW, Pujades-Rodriguez M & Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 4, e5790.
9. Caluwaerts C, Maendaenda R, Maldonado F et al. (2009) Risk factors and true outcomes for lost to follow-up individuals in an antiretroviral treatment programme in Tete, Mozambique. International Health 1, 97-101.
10. Chima I & Lupondwana P (2011) How soon should ART defaulters be traced? Characteristics and outcomes of defaulters attending an antiretroviral treatment clinic in Vryheid Hospital, South Africa. 6th IAS Conference on HIV Pathogenesis and Treatment, 2011 Rome. Abstract no. MOPE466.
11. Dahab M, Kielmann K, Charalambous S et al. (2011) Contrasting reasons for discontinuation of antiretroviral therapy in workplace and public-sector HIV programs in South Africa. Aids Patient Care and STDS 25, 53-59.
12. Dalal RP, Macphail C, Mqhayi M et al. (2008) Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. Journal of Acquired Immune Deficiency Syndromes 47, 101-107.
13. Decroo T, Telfer B, Biot M et al. (2011) Distribution of antiretroviral treatment through self-forming groups of patients in Tete province, Mozambique. Journal of Acquired Immune Deficiency Syndromes 56, e39-e44.
14. Deribe K, Hailekiros F, Biadgilign S et al. (2008) Defaulters from antiretroviral treatment in Jimma University Specialized Hospital, Southwest Ethiopia. Tropical Medicine & International Health 13, 328-333.
15. Egger M, Spycher BD, Sidle J et al. (2011) Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. PLoS Medicine 8, e1000390.
16. Fatti G, Grimwood A & Bock P (2010) Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces. PLoS One 5, e12888.
17. Fox MP & Rosen S (2010) Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Tropical Medicine & International Health 15(Suppl. 1), 1-15.
18. Fox MP, Larson B & Rosen S (2012) Defining retention and attrition in pre-antiretroviral HIV care: proposals based on experience in Africa. Tropical Medicine & International Health 17, 1235-1244.
19. Freeman M (1950) Transformations related to the angular and the square root. Annals of Mathematical Statistics 21, 607-611.
20. Geng EH, Glidden DV, Emenyonu N et al. (2010a) Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Tropical Medicine & International Health 15(Suppl. 1), 63-69.
21. Geng EH, Nash D, Kambugu A et al. (2010b) Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Current HIV/AIDS Reports 7, 234-244.
22. Geng EH, Glidden DV, Bwana MB et al. (2011) Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach. PLoS One 6, e21797.
23. Grimsrud A, Patten G, Sharp J et al. (2013) Extending dispensing intervals for stable patients on ART. Journal of Acquired Immune Deficiency Syndromes 66, e58-e60.
24. Grimsrud A, Balkan S, Casas EC et al. (2014) Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programmes. Journal of Acquired Immune Deficiency Syndromes 67(2), e55-e66.
25. Gunguwo H, Chaibva C, Maseko U et al. (2012) True outcomes of patients lost to follow-up on antiretroviral therapy at a large central hospital OI/ART clinic in Bulawayo, Zimbabwe. 19th International AIDS Conference, 2012 Washington. Abstract no. TUPE064.
26. Gupta A, Nadkarni G, Yang W-T et al. (2011) Early mortality in adults initiating antiretroviral therapy (ART) in low-and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS One 6, e28691.
27. Harries AD, Zachariah R, Lawn SD & Rosen S (2010) Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Tropical Medicine & International Health 15(Suppl. 1), 70-75.
28. Higgins JP, Thompson SG, Deeks JJ & Altman DG (2003) Measuring inconsistency in meta-analyses. British Medical Journal 327, 557.
29. Jüni P, Witschi A, Bloch R & Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282, 1054-1060.
30. Kato T, Yasutaka Y, Komada K et al. (2013) Further investigation to address the details of the poor outcome based on prospective cohort study of HIV-infected patients in rural area of Zambia. 7th IAS Conference on HIV Pathogenesis and Treatment, 2013 Kuala Lumpur. Abstract no. TULBPE38.
31. Krebs DW, Chi BH, Mulenga Y et al. (2008) Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care 20, 311-317.
32. Liberati A, Altman DG, Tetzlaff J et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. British Medical Journal 339, b2700.
33. Lowrance DW, Makombe S, Harries AD et al. (2008) A public health approach to rapid scale-up of antiretroviral treatment in Malawi during 2004-2006. Journal of Acquired Immune Deficiency Syndromes 49, 287-293.
34. Marson KG, Tapia K, Kohler P et al. (2013) Male, mobile, and moneyed: loss to follow-up vs. transfer of care in an Urban African antiretroviral treatment clinic. PLoS One 8, 10.
35. Maskew M, MacPhail P, Menezes C & Rubel D (2007) Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy. South African Medical Journal 97, 853-857.
36. Mben J, Kouanfack C, Essomba C et al. (2012) Operational research and HIV policy and guidelines: lessons from a study of patients lost to follow-up from a public antiretroviral treatment program in Cameroon. Journal of Public Health Policy 33, 462-477.
37. McGuire M, Munyenyembe T, Szumilin E et al. (2010) Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Tropical Medicine & International Health 15(Suppl. 1), 55-62.
38. McMahon JH, Elliott JH, Hong SY et al. (2013) Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review. PLoS One 8, e56047.
39. Miller J (1978) The Inverse of the Freeman-Tukey Double Arcsine transformation. The American Statistician 32, 138.
40. Miller CM, Ketlhapile M, Rybasack-Smith H & Rosen S (2010) Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Tropical Medicine & International Health 15(Suppl. 1), 48-54.
41. Moher D, Liberati A, Tetzlaff J & Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. British Medical Journal 339, b2535.
42. Mutevedzi PC, Lessells RJ & Newell M (2013) Disengagement from care in a decentralised primary health care antiretroviral treatment programme: cohort study in rural South Africa. Tropical Medicine & International Health 18, 934-941.
43. Nglazi MD, Kaplan R, Orrell C et al. (2013) Increasing transfers-out from an antiretroviral treatment service in South Africa: patient characteristics and rates of virological non-suppression. PLoS One 8, e57907.
44. O'Connor C, Osih R & Jaffer A (2011) Loss to follow-up of stable antiretroviral therapy patients in a decentralized down-referral model of care in Johannesburg, South Africa. Journal of Acquired Immune Deficiency Syndromes 58, 429-432.
45. Omotoso O (2011) Experiences and challenges of a novel tracking approach to enhance client retention in rural HIV clinics of North East Nigeria. 6th IAS Conference on HIV Pathogenesis and Treatment, 2011 Rome. Abstract no. MOPE433.
46. Onoka CA, Uzochukwu BS, Onwujekwe OE et al. (2012) Retention and loss to follow-up in antiretroviral treatment programmes in southeast Nigeria. Pathogens and Global Health 106, 46-54.
47. Peltzer K, Ramlagan S, Khan MS & Gaede B (2011) The social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study. Sahara J 8, 179-186.
48. Rosen S & Ketlhapile M (2010) Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa. Tropical Medicine & International Health 15(Suppl. 1), 98-104.
49. Rücker G, Schwarzer G, Carpenter JR & Schumacher M (2008) Undue reliance on I2 in assessing heterogeneity may mislead. BMC medical research methodology 8, 79.
50. Saka B, Landoh DE, Patassi A et al. (2013) Loss of HIV-infected patients on potent antiretroviral therapy programs in Togo: risk factors and the fate of these patients. Pan African Medical Journal 15, 45.
51. van Schalkwyk C, Mndzebele S, Hlophe T et al. (2013) Outcomes and impact of HIV prevention, ART and TB programs in Swaziland-Early evidence from public health triangulation. PLoS One 8, e69437.
52. Shepherd BE, Blevins M, Vaz LM et al. (2013) Impact of definitions of loss to follow-up on estimates of retention, disease progression, and mortality: application to an HIV program in Mozambique. American Journal of Epidemiology 178, 819-828.
53. Sie C, Anthony T, Essoi B et al. (2011) Using cell phones to track patients lost-to-follow up (LTFU): the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)'s experience in Cote d'Ivoire. 6th IAS Conference on HIV Pathogenesis and Treatment, 2011 Rome. Abstract no. MOPE478.
54. StataCorp. (2013). Stata Statistical Software: Release 13IC [Online]. StataCorp LP, College Station, Texas, USA.
55. Toure S, Dakoury N, Adouko S et al. (2012) Using an individualized data base, phone calls and home visits to improve the patients tracking. 19th International AIDS Conference, 2012 Washington. Abstract no. TUPE676.
56. Tweya H, Feldacker C, Estill J et al. (2013) Are they really lost? "True" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi. PLoS One 8, (9).
57. Umscheid CA (2013) A primer on performing systematic reviews and meta-analyses. Clinical Infectious Diseases 57, 725-734.
58. Van Cutsem G, Ford N, Hildebrand K et al. (2011) Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis. PLoS One 6, e14684.
59. Weigel R, Hochgesang M, Brinkhof MW et al. (2011) Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi. BMC Infectious Disease 11, 31.
60. WHO (2008) Operations manual for delivery of HIV prevention, care and treatment at primary health centres in high-prevalence, resource-constrained settings [Online]. World Health Organization. Available: http://www.who.int/hiv/pub/imai/operations_manual/en/ (Accessed 28 May 2014).
61. WHO (2013) Global update on HIV treatment 2013: Results, impact and opportunities [Online]. WHO; UNICEF; UNAIDS. Available: http://apps.who.int/iris/bitstream/10665/85326/1/9789241505734_eng.pdf (Accessed 16 July 2014).
62. Wubshet M, Berhane Y, Worku A & Kebede Y (2013) Death and seeking alternative therapy largely accounted for lost to follow-up of patients on ART in northwest Ethiopia: a community tracking survey. PLoS One 8, e59197.
63. Yu JK, Chen SC, Wang KY et al. (2007) True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bulletin of the World Health Organization 85, 550-554.